404 related articles for article (PubMed ID: 17548657)
1. A previously unrecognized protein-protein interaction between TWEAK and CD163: potential biological implications.
Bover LC; Cardó-Vila M; Kuniyasu A; Sun J; Rangel R; Takeya M; Aggarwal BB; Arap W; Pasqualini R
J Immunol; 2007 Jun; 178(12):8183-94. PubMed ID: 17548657
[TBL] [Abstract][Full Text] [Related]
2. Soluble macrophage-derived CD163: a homogenous ectodomain protein with a dissociable haptoglobin-hemoglobin binding.
Møller HJ; Nielsen MJ; Maniecki MB; Madsen M; Moestrup SK
Immunobiology; 2010 May; 215(5):406-12. PubMed ID: 19581020
[TBL] [Abstract][Full Text] [Related]
3. Studies of binding of tumor necrosis factor (TNF)-like weak inducer of apoptosis (TWEAK) to fibroblast growth factor inducible 14 (Fn14).
Fick A; Lang I; Schäfer V; Seher A; Trebing J; Weisenberger D; Wajant H
J Biol Chem; 2012 Jan; 287(1):484-495. PubMed ID: 22081603
[TBL] [Abstract][Full Text] [Related]
4. TWEAK mediates signal transduction and differentiation of RAW264.7 cells in the absence of Fn14/TweakR. Evidence for a second TWEAK receptor.
Polek TC; Talpaz M; Darnay BG; Spivak-Kroizman T
J Biol Chem; 2003 Aug; 278(34):32317-23. PubMed ID: 12794080
[TBL] [Abstract][Full Text] [Related]
5. Comparative assessment of the recognition of domain-specific CD163 monoclonal antibodies in human monocytes explains wide discrepancy in reported levels of cellular surface CD163 expression.
Maniecki MB; Etzerodt A; Moestrup SK; Møller HJ; Graversen JH
Immunobiology; 2011 Aug; 216(8):882-90. PubMed ID: 21458881
[TBL] [Abstract][Full Text] [Related]
6. TWEAK binding to the Fn14 cysteine-rich domain depends on charged residues located in both the A1 and D2 modules.
Brown SA; Hanscom HN; Vu H; Brew SA; Winkles JA
Biochem J; 2006 Jul; 397(2):297-304. PubMed ID: 16526941
[TBL] [Abstract][Full Text] [Related]
7. The CD163-expressing macrophages recognize and internalize TWEAK: potential consequences in atherosclerosis.
Moreno JA; Muñoz-García B; Martín-Ventura JL; Madrigal-Matute J; Orbe J; Páramo JA; Ortega L; Egido J; Blanco-Colio LM
Atherosclerosis; 2009 Nov; 207(1):103-10. PubMed ID: 19473660
[TBL] [Abstract][Full Text] [Related]
8. The TWEAK/Fn14/CD163 axis-implications for metabolic disease.
Ratajczak W; Atkinson SD; Kelly C
Rev Endocr Metab Disord; 2022 Jun; 23(3):449-462. PubMed ID: 34542797
[TBL] [Abstract][Full Text] [Related]
9. Scavenger receptor CD163, a Jack-of-all-trades and potential target for cell-directed therapy.
Van Gorp H; Delputte PL; Nauwynck HJ
Mol Immunol; 2010 Apr; 47(7-8):1650-60. PubMed ID: 20299103
[TBL] [Abstract][Full Text] [Related]
10. Structural basis and targeting of the interaction between fibroblast growth factor-inducible 14 and tumor necrosis factor-like weak inducer of apoptosis.
Dhruv H; Loftus JC; Narang P; Petit JL; Fameree M; Burton J; Tchegho G; Chow D; Yin H; Al-Abed Y; Berens ME; Tran NL; Meurice N
J Biol Chem; 2013 Nov; 288(45):32261-32276. PubMed ID: 24056367
[TBL] [Abstract][Full Text] [Related]
11. Fibroblast growth factor inducible (Fn14)-specific antibodies concomitantly display signaling pathway-specific agonistic and antagonistic activity.
Salzmann S; Seher A; Trebing J; Weisenberger D; Rosenthal A; Siegmund D; Wajant H
J Biol Chem; 2013 May; 288(19):13455-66. PubMed ID: 23532848
[TBL] [Abstract][Full Text] [Related]
12. CD163 binding to haptoglobin-hemoglobin complexes involves a dual-point electrostatic receptor-ligand pairing.
Nielsen MJ; Andersen CB; Moestrup SK
J Biol Chem; 2013 Jun; 288(26):18834-41. PubMed ID: 23671278
[TBL] [Abstract][Full Text] [Related]
13. The macrophage scavenger receptor CD163 functions as an innate immune sensor for bacteria.
Fabriek BO; van Bruggen R; Deng DM; Ligtenberg AJ; Nazmi K; Schornagel K; Vloet RP; Dijkstra CD; van den Berg TK
Blood; 2009 Jan; 113(4):887-92. PubMed ID: 18849484
[TBL] [Abstract][Full Text] [Related]
14. Identification of aurintricarboxylic acid as a selective inhibitor of the TWEAK-Fn14 signaling pathway in glioblastoma cells.
Roos A; Dhruv HD; Mathews IT; Inge LJ; Tuncali S; Hartman LK; Chow D; Millard N; Yin HH; Kloss J; Loftus JC; Winkles JA; Berens ME; Tran NL
Oncotarget; 2017 Feb; 8(7):12234-12246. PubMed ID: 28103571
[TBL] [Abstract][Full Text] [Related]
15. TWEAK-independent Fn14 self-association and NF-κB activation is mediated by the C-terminal region of the Fn14 cytoplasmic domain.
Brown SA; Cheng E; Williams MS; Winkles JA
PLoS One; 2013; 8(6):e65248. PubMed ID: 23750247
[TBL] [Abstract][Full Text] [Related]
16. Role of the tumour necrosis factor-like weak inducer of apoptosis (TWEAK)/fibroblast growth factor-inducible 14 (Fn14) axis in autoimmune thyroid disease.
Peng S; Yu X; Zhao X; Wang X; Sun X; Han C; Shan Z; Li C; Teng W
Clin Endocrinol (Oxf); 2017 Dec; 87(6):783-790. PubMed ID: 28636775
[TBL] [Abstract][Full Text] [Related]
17. Plasma clearance of hemoglobin and haptoglobin in mice and effect of CD163 gene targeting disruption.
Etzerodt A; Kjolby M; Nielsen MJ; Maniecki M; Svendsen P; Moestrup SK
Antioxid Redox Signal; 2013 Jun; 18(17):2254-63. PubMed ID: 22793784
[TBL] [Abstract][Full Text] [Related]
18. TWEAK, a member of the TNF superfamily, is a multifunctional cytokine that binds the TweakR/Fn14 receptor.
Wiley SR; Winkles JA
Cytokine Growth Factor Rev; 2003; 14(3-4):241-9. PubMed ID: 12787562
[TBL] [Abstract][Full Text] [Related]
19. Functional expression of TWEAK and the receptor Fn14 in human malignant ovarian tumors: possible implication for ovarian tumor intervention.
Gu L; Dai L; Cao C; Zhu J; Ding C; Xu HB; Qiu L; Di W
PLoS One; 2013; 8(3):e57436. PubMed ID: 23469193
[TBL] [Abstract][Full Text] [Related]
20. Regulation of tumor necrosis factor-like weak inducer of apoptosis receptor protein (TWEAKR) expression by Kaposi's sarcoma-associated herpesvirus microRNA prevents TWEAK-induced apoptosis and inflammatory cytokine expression.
Abend JR; Uldrick T; Ziegelbauer JM
J Virol; 2010 Dec; 84(23):12139-51. PubMed ID: 20844036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]